Kintara
Kintara is a California-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of cancer.
Business Model:
Revenue: $0
Employees: 2-10
Rankings
Industries / Tags:
Detailed Kintara Information
Geographic Data
Address: 9920 Pacific Heights Blvd,
City: San Diego
State: CA
Zip: 92121
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$20M
Raised Total:$74M
Social
Metrics
7,125,875Website Global Rank
934Website Monthly Traffic
Twitter Followers
Description
Kintara is a California-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of cancer.
Contact Phone:
+18583504364
Contact Email:
Kintara went public on 7/12/2016 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
7/12/2016
Ticker Symbol:
KTRA
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 9/2020 | Post-IPO Equity | $25M | 6/2019 | Post-IPO Equity | - | 4/2017 | Post-IPO Equity | $9M | 5/2016 | Post-IPO Equity | $5.6M | 8/2022 | Post-IPO Equity | $0 |
Lincoln Park Capital Fund Lincoln Park Capital Fund |
1/2022 | Grant | - |
Luxembourg National Research Fund Luxembourg National Research Fund |
4/2022 | Post-IPO Equity | $8.6M | 4/2022 | Post-IPO Equity | $8.6M | 8/2020 | Private Placement | $25M | 8/2020 | Private Placement | $2.4M | 6/2020 | Debt | $500k |
National Brain Tumor Society National Foundation for Cancer Research |
5/2016 | Post-IPO Equity | 1 | $9.5M |
SternAegis SternAegis |
9/2021 | Post-IPO Equity | $15M | 8/2015 | Post-IPO Equity | $2.6M | 6/2020 | Post-IPO Equity | $25M | 3/2013 | Post-IPO Equity | $10.5M | 8/2022 | Post-IPO Equity | 1 | $20M |
Lincoln Park Capital Fund Lincoln Park Capital Fund |
1/2022 | Grant | 1 | - |
Luxembourg National Research Fund Luxembourg National Research Fund |
6/2019 | Post-IPO Equity | - |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 6/2020 | Adgero Biopharmaceuticals |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
